20131104_full_cv

CURRICULUM VITAE

Address:
Department of Mathematical Statistics and Actuarial Science
Telephone:

Date of Birth:

Place of Birth:

Marital Status:
Married to Gina Joubert. Two sons: Paul and Philip.
Nationality:

Home Language: German
Other Languages: English, Afrikaans, Dutch (reading ability)
Academic Qualifications
1986: PhD in Mathematical Statistics, University of Cape Town.
1984: Diplom-Mathematiker, University of Karlsruhe, Germany.
1983: BSc (Hons) in Mathematical Statistics, University of Cape Town.
1977: Zeugnis der Hochschulreife (Matric), Gymnasium am Kaiserdom,
Present Occupation
Departmental Chairman and Professor of Statistics, Department of
Mathematical Statistics and Actuarial Science, University of the Free State
Previous Positions
Quintiles:
Director of Biostatistics; General Manager
University of the Free State:
Professor of Statistics (part-time).
Associate Professor and Head, Division (from 1995:
Department) of Biostatistics.
Director (Biometry), FARMOVS Research Centre.
SA Medical Research Council, Institute for Biostatistics:
Biometrician; Senior Biometrician;
Chief Biometrician

Messerschmitt-Bölkow-Blohm GmbH:
Mathematician.
Publications (detailed list attached below)
Peer-reviewed scientific articles:
Other articles in peer-reviewed journals:
Chapters in books:
Literary translations
Other articles

Foundation for Research Development (FRD) Rating
1997 – 2000: B
1993 – 1996: P (President’s Award)
Major Professional Achievements
1997: Co-founder (with Herman Luus and Theo Erasmus): ClinData (later
Quintiles ClinData).
1995: Founder and first Head: Department of Biostatistics, Faculty of
Medicine, University of the Orange Free State. 1993: President's Award of the Foundation for Research Development.
1997: John van der Riet Medal for the Best Clinical Publication at the
Faculty of Medicine, University of the Orange Free State. 1996: Muller Potgieter Medal for the Best Non-Clinical Publication at the
Faculty of Medicine, University of the Orange Free State. 1995: Fellow of the South African Statistical Association.
John van der Riet Medal for the Best Clinical Publication at the
Faculty of Medicine, University of the Orange Free State.
1993: Muller Potgieter Medal for the Best Non-Clinical Publication at the
Faculty of Medicine, University of the Orange Free State. President's Award of the Foundation for Research Development
(FRD P rating).
1983: Scholarship of the South African Department of National Education
for a year of study at the University of Cape Town. Other Appointments
Associate Editor: South African Statistical Journal.
Associate Editor: Biometrics.
Associate Editor: South African Statistical Journal.
consultant:
Statistics Working Group, Centre for Drug Evaluation and Research, Food and Drug Administration, USA. Member: Grants Committee, South African Medical
Research Council.

Member: Research Committee, Faculty of Medicine,
University of the Orange Free State.

Referee for various scientific journals in the fields of statistics and clinical
pharmacology, such as Biometrics, Biometrika, Cardiovascular Journal of
Africa, Journal of Biopharmaceutical Statistics, Journal of Pharmacy &
Pharmaceutical Sciences, Journal of the American Statistical Association,
Pharmaceutical Statistics, South African Statistical Journal, South African
Medical Journal, Statistics in Medicine, Statistical Science, Technometrics.

Invited Lectures / Invited Academic Activities (selection)
2011: TQT Colloquium, Boehringer Ingelheim Pharma, Biberach, Germany.
2011: Second
International
Symposium
on
Biopharmaceutical
Statistics, Berlin, Germany. Invited lecture.
2010: Joint Statistical Meetings, Vancouver, Canada. Invited paper in
2009: 3rd Annual Clinical Forum, Drug Information Association (DIA), Nice,
2009: National Association of Pharmaceutical Manufacturers (NAPM)
Conference, Johannesburg, South Africa. Invited lecture.
2005, 2007, 2008: Basic Course on Pharmacokinetics, Bioavailability
and Bioequivalence, German Association of Clinical Pharmacology,
Friedewald, Germany. Invited to present workshop module.
2005: Advanced Course on Pharmacokinetics, Bioavailability and
Bioequivalence, German Association of Clinical Pharmacology.
Invited to present workshop module.
1998: University of Hong Kong Clinical Trials Centre, Hong Kong Invited
1998: American Association of Pharmaceutical Sciences Meeting
International Workshop on Individual Bioequivalence, Montreal,
Canada. Invited paper and panel member.
1996: Bio-International 3, Tokyo, Japan. Invited paper.
1995: US Food and Drug Administration, Washington DC, USA. Invited
1995: International
Workshop
on
Bioequivalence,
Düsseldorf, Düsseldorf, Germany. Invited lecture. 1994: Joint Statistical Meetings, Toronto, Canada. Invited lecture.
1994: Bio-International 2, Munich, Germany. Invited paper.
1993: US Food and Drug Administration, Washington DC, USA. Invited to
participate in Expert Meeting on Individual Bioequivalence. 1989: University of Minnesota “Diagnostics Quarter”, St. Paul, USA.
1989: Joint Statistical Meetings, Washington DC, USA. Invited lecture.
1989: Institute for Mathematics and its Applications (IMA) Summer
Program on Robust Statistics, Minneapolis, USA. Invited participant.
Postgraduate Students
2012: Linda van der Merwe (PhD). Thesis: An analysis of the field of
statistics education with special reference to computer-assisted teaching and learning. (Co-promotor) Louwrens Potgieter (MSc) (with distinction). Thesis: Assessing a
brain-computer interface by evoking the auditory cortex through
binaural beats. (Co-supervisor)
Paulinah Makopela (MCom). Mini-thesis: Socio-economic Impact of
Antiretroviral Treatment (ART) on Labour Market Outcomes. (Co-
supervisor)
2011: Dianne Weatherall (MSc) (with distinction). Thesis: Cross-validation
of rain rules for interrupted one-day cricket matches. Ruaan van Zyl (MSc) (with distinction). Mini-thesis: Least-squares
estimation based on order statistics in some location-scale families.
2010: Roland Klopper (MSc). Mini-thesis: Baseline adjustment in thorough
2009: Alex Brink (MSc). Mini-thesis: Overview of missing data methods in
Paul Malan (MSc). Mini-thesis: Aspects of the statistical analysis of
immunotherapy clinical trials.
Divan Burger (MSc) (with distinction). Mini-thesis: Statistical
analysis of replicate design cross-over studies.
2007: Euodia Bezuidenhoudt (MSc). Mini-thesis: Accuracy and precision of
AUCt and AUC∞ as characteristics of relative bioavailability in bioequivalence Studies. Mauritz Bezuidenhoudt (MSc) (with distinction). Mini-thesis: The
empirical coverage of Student’s t confidence interval.
Illze Crous (MSc). Mini-thesis: Review of non-parametric methods for
the assessment of bioequivalence.
2004: Sharon Rossouw (MMedSc) (with distinction). Thesis: Profile of
clinical trial biostatisticians and university courses to train them in South Africa. (Co-supervisor) 2003: Perpetual Chikobvu (PhD). Thesis: Randomised placebo-controlled
trial to evaluate the effectiveness of Vitamin A on mother-to-child transmission of HIV-1 in Bloemfontein. 1998: Mariette Nel (MMedSc). Thesis: Assessment of different methods of
determining confidence intervals for the difference of binomial proportions. 1997: Linda Potgieter (PhD). Thesis: Comparison of the sensitivity and
power of absorption rate characteristics in steady-state bioequivalence studies. 1996: Ronelle Goosen (MMedSc). Thesis: A simulation study to determine
sample sizes for the assessment of individual bioequivalence. Frank Müller (MMedSc) (with distinction). Thesis: The influence of
grapefruit and guava juice, in relation to time of administration, on the
pharmacokinetics and pharmacodynamics of nifedipine in male
volunteers.
1995: Helena Nel (MMedSc). Thesis: Statistical analysis of dose-
1993: Theo Erasmus (MMedSc). Thesis: Statistical analysis of safety data in
List of Publications
1. BLU-Schätzung im linearen Model mit unbekannten Varianzkomponenten. Unpublished Diplomarbeit: University of Karlsruhe, Germany, 1984 2. Outliers and influence under arbitrary variance. Unpublished PhD thesis: University of Cape Town, South Africa, 1986

Peer-reviewed scientific articles

1. Schall R, Dunne TT (1986). Transformation and reparametrization for best linear
unbiased estimation of a linear model with arbitrary known variance. Communications in Statistics, B15, 905—916 2. Schall R, Dunne TT (1987). Additional variables and adjusted estimates with arbitrary known variance-covariance structure. Communications in Statistics, A16, 1253—1263 3. Schall R, Dunne TT (1987). A note on the chisquaredness of quadratic forms. 4. Schall R, Dunne TT (1987). On outliers and influence in the general multivariate normal linear model. In: Proceedings of the Second International Tampere Conference in Statistics. Pukkila T, Puntanen S (eds). Tampere: University of Tampere, 665—678 5. Cohen JC, Schall R (1988). Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals. American Journal of Clinical Nutrition, 48, 1031—1034 6. Schall R, Dunne TT (1988). A unified approach to outliers in the general linear model. Sankhya, Ser. B, 50, 157—167 7. Schall R (1989). A note on variable selection in linear models. South African Statistical Journal, 23, 183—194 8. Noakes TD, Myburgh C, Schall R (1990). Peak treadmill running velocity during the VO2max test predicts running performance. Journal of Sports Science, 8, 35—45 9. Padayachee GN, Schall R (1990). Short term predictions of the prevalence of human immunodeficiency virus infection among the black population in South Africa. South African Medical Journal, 77, 329—333 10. Schall R, Zucchini W (1990). Model selection and the estimation of odds ratios in the presence of extraneous factors. Statistics in Medicine, 9, 1131—1141 11. Schall R (1990) On the maximum size of the AIDS epidemic among the heterosexual black population of South Africa. South African Medical Journal, 78, 507—510 12. Van der Spuy ZM, Sohnius U, Pienaar C and Schall R (1990). Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception, 42, 597—609 13. Schall R, Dunne TT (1990). Influential variables in linear regression. 14. Schall R, Dunne TT (1990). Diagnostics for regression-ARMA time series. In: Directions in Robust Statistics: Part II. Stahel W, Weisberg S (eds). New York: Springer, 205—221 15. Fincham JE, Gouws E, Woodroof CW, Van Wyk MJ, Kruger M, Smuts CM, van Jaarsveld PJ, Taljaard JJF, Schall R, Strauss JA de W, Benadé AJS (1991). Chronic effects of fish oil and a therapeutic diet in nonhuman primates. Arteriosclerosis and Thrombosis, 11, 719—732 16. Schall R, Gonin R (1991). Diagnostics for nonlinear Lp-norm estimation. Computational Statistics and Data Analysis, 11, 189—198 17. Schall R (1991). Estimation in generalized linear models with random effects. 18. Noakes TD, Myburgh KH, Du Plessis J, Lang L, Lambert M, Van der Riet, Schall R (1991). Metabolic rate, non percent dehydration, predicts rectal temperature in marathon runners. Medicine and Science in Sports and Exercise, 23, 443—449 19. Schall R, Luus HG (1992). Comparison of absorption rates in bioequivalence studies of immediate release drug formulations. International Journal of Clinical Pharmacology, Therapy and Toxicology, 30, 153—159 20. Schall R, Dunne TT (1992). A note on the relationship between parameter collinearity and local influence. Biometrika, 79, 399—404 21. Schall R, Groenewoud G, Hundt HKL, Müller FO, Oelofsen MJ, Ungerer MJ, Wessels PH, Hogendoorn CYA (1992). Pharmacokinetic profile of aprotinin (Trasylol®) in female patients undergoing primary elective hysterectomy. Drug Investigation, 4, 292—299 22. Schall R (1992). Estimating treatment effects when subjects learn from the pre- test. South African Statistical Journal, 26, 61—77 23. Smuts CM, Kruger M, Van Jaarsveld PJ, Fincham JE, Schall R, Van der Merwe KJ, Benadé AJS (1992). The influence of fish oil supplementation on plasma lipoproteins and arterial lipids in vervet monkeys with established atherosclerosis. Prostaglandins Leukotrienes and Essential Fatti Acids, 47, 129—138 24. Moodley D, Noakes TD, Bosch AN, Hawley JA, Schall R, Dennis SC (1992). Oxidation of exogenous carbohydrate during prolonged exercise: the effect of carbohydrate type and concentration. European Journal of Applied Physiology, 64, 328—334 25. Müller FO, Schall R, Groenewoud G, Hundt HKL, Van der Merwe JC, Van Dyk M (1993). The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout. European Journal of Clinical Pharmacology, 44, 69—72 26. Crome P, Müller FO, Wijayawardhana P, Groenewoud G, Hundt HKL, Leighton G, Luus HG, Schall R, Van Dyk M (1993). Single dose and steady-state pharmacokinetic profiles of nifedipine GITS tablets in healthy elderly and young volunteers. Drug Investigation, 5, 193—199 27. Müller FO, Henry J, Schall R, Groenewoud G, Hundt HKL, Luus HG, Van Dyk M (1993). Single dose and steady-state pharmacokinetic profiles of nifedipine coat-core tablets in healthy elderly and young volunteers. Drug Investigation, 5, 243—249 28. Cronje HS, Kruger JAVH, Bam RH, Muir AR, Müller FO, Schall R, Goldberg N, Wende LM (1993). Die effektiwiteit van Poly-Gynedron® in die behandeling van vaginitis. Geneeskunde, 22—33 29. Schall R, Middle MV, Müller FO, Du Plessis JP (1993). Theophylline dose- concentration relationship of a 12-hourly Nuelin SA regimen supplemented with nocturnal Nuelin Liquid in healthy volunteers. Chronobiology International, 10, 224—233 30. Middle MV, Müller FO, Schall R, Le Roux FPJ, Du Plessis JP (1993). Double- blind randomised cross-over trial of nocturnal theophylline supplementation of a twice-daily sustained release theophylline tablet formulation. Chronobiology International, 10, 277—289 31. Schall R, Luus HG (1993). On population and individual bioequivalence. Statistics in Medicine, 12, 1109—1124 32. Hundt HKL, Schall R, Luus HG, Müller FO (1993). Considerable cost savings through the analysis of pooled plasma samples in bioequivalence studies that fail to show bioequivalence. International Journal of Clinical Pharmacology, Therapy and Toxicology, 31, 331—336 33. Groenewoud G, Schall R, Hundt HKL, Müller FO, Van Dyk M (1993). Steady- state pharmacokinetics of phentermine extended-release capsules. International Journal of Clinical Pharmacology, Therapy and Toxicology, 31, 368—372 34. De la Rey N, Schall R, Luus HG, Meyer BH, Müller FO (1993). Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives. International Journal of Clinical Pharmacology, Therapy and Toxicology, 31, 435—439 35. Conradie C, Schall R, Marx JD (1993). Echocardiographic study of left atrial thrombi in mitral stenosis. Clinical Cardiology, 16, 729—731 36. Pieters H, Roodt JP, Badenhorst PN, van Wyk V, Schall R, Lötter MG, Hundt HKL, Nel CJC (1993). Antithrombotic activity of Bay u3405, a thromboxane A2-antagonist, in patients with Dacron aortic grafts: a random controlled clinical trial. Thrombosis and Haemostasis, 70, 903—908 37. Schall R, Müller FO, Hundt HKL, Groenewoud G, Oelofsen MJ, Ungerer MJ, Wessels PH, Schumann F (1994). Pharmacokinetic profile of high doses of aprotinin in patients undergoing primary elective hysterectomy. A meta-analysis of two clinical trials. Drug Investigation, 7, 200-208 38. Furman S, Berkowicz L, Dippenaar J, Hellenberg DA, Montanus MS, Steinberg A, Schall R (1994). Cefetamet pivoxil vs cefaclor in the treatment of acute otitis media in children. Drugs, 47 (Suppl 3), 21—26 39. Schall R, Luus HG, Steinijans VW, Hauschke D (1994). Choice of characteristics and their bioequivalence ranges for comparison of absorption rates of immediate-release drug formulations. International Journal of Clinical Pharmacology and Therapeutics, 32, 323—328 40. Hauschke D, Steinijans VW, Diletti E, Schall R, Luus HG, Elze M, Blume H (1994). Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies. International Journal of Clinical Pharmacology and Therapeutics, 32, 376—378 41. Van der Meyden CH, Kruger AJ, Müller FO, Rabie W, Schall R (1994). Acute oral loading of carbamazepine-SR and phenytoin in a double-blind randomized study of patients at risk of seizures. Epilepsia, 35, 189—194 42. Schall R, Müller FO, Groenewoud G, Hundt HKL, Van Dyk M (1994). Relative bioavailability of four controlled-release nifedipine products. Biopharmaceutics and Drug Disposition, 15, 493—503 43. Schall R, Müller FO, Groenewoud G, Mogilnicka EM, van Dyk M (1994). Single- dose and steady-state pharmacokinetic and pharmacodynamic profiles of nisoldipine coat-core tablets in healthy young, and healthy elderly, and elderly hypertensive volunteers. Drug Investigation, 8, 21—30 44. Schall R, Müller FO, Groenewoud G, Hundt HKL, Luus HG, van Dyk M, van Schalkwyk AMC (1994). Investigation of a possible pharmacokinetic interaction between nisoldipine and quinidine in healthy volunteers. Drug Investigation, 8, 162—170 45. Swart MJ, Gordon PC, Hayse-Gregson PB, Dyer RA, Swanepoel AL, Buckels NJ, Schall R, Odell JA (1994). High dose aprotinin in cardiac surgery - a prospective, randomised study. Anaesthesia and Intensive Care, 22, 529—533 46. Schall R, Hundt HKL, Luus HG (1994). Pharmacokinetic characteristics for extent of absorption and clearance in drug/drug interaction studies. International Journal of Clinical Pharmacology and Therapeutics, 32, 633—637 47. Groenewoud G, Hundt HKL, Luus HG, Müller FO, Schall R (1994). Absolute bioavailability of a new high dose methylprednisolone tablet formulation. International Journal of Clinical Pharmacology and Therapeutics, 32, 652—654 48. Otto AC, Ninham E, Pretorius PH, Wagner L, du Toit DJR, Schall R (1994). Difference between splenic volume measured at necropsy and that measured in vivo by radionuclide tomography. Clinical Nuclear Medicine, 19, 979—980 49. Gagiano CA, Hart GAD, Bodemer W, Schall R (1994). Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicentre comparison 50. Slabber M, Barnard HC, Kuyl JM, Dannhauser A, Schall R (1994). Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females. American Journal of Clinical Nutrition, 60, 48—53 51. De Wet EH, Schall R, Oosthuizen JMC (1994). Basale sekresie van endogene opioiede na intraveneuse naloksoon (Letter). South African Medical Journal, 84, 51 52. Middle MV, Müller FO, Schall R, Hundt HKL, Mogilnicka EM, Beneke PC (1995). Effect of pantoprazole on ovulation suppression by a low-dose hormonal contraceptive. Clinical Drug Investigation, 54—56 53. Meyer BH, Scholtz HE, Schall R, Müller FO, Hundt HKL, Maree JS (1995). The effect of fasting on total serum bilirubin concentrations. British Journal of Clinical Pharmacology, 39, 169—171 54. Middle MV, Müller FO, Schall R, Groenewoud G, Hundt HKL, Huber R, Bliesath H, Steinijans VW (1995). No influence of pantoprazole on the pharmacokinetics of phenytoin. International Journal of Clinical Pharmacology and Therapeutics, 33, 304—307 55. Duursema L, Müller FO, Schall R, Middle MV, Hundt HKL, Groenewoud G, Steinijans VW, Bliesath H (1995). Lack of effect of pantoprazole on the pharmacokinetics and pharmacodynamics of warfarin. British Journal of Clinical Pharmacology, 39, 700—703 56. Steinijans VW, Sauter R, Hauschke D, Diletti E, Schall R, Luus HG, Elze M, Blume H, Hoffmann C, Franke G, Siegmund W (1995). Reference tables for the intrasubject coefficient of variation in bioequivalence studies. International Journal of Clinical Pharmacology and Therapeutics, 33, 427—430 57. Schall R (1995). Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar. Biometrics, 51, 615—626 58. Conradie C, Schall R, Marx JD (1995). Left atrial size - a risk factor for left atrial thrombi in mitral stenosis. Clinical Cardiology, 18, 518—520 59. Steinijans VW, Hauschke D, Schall R (1995). International harmonization of regulatory bioequivalence requirements for average bioequivalence and current issues in individual bioequivalence. Drug Information Journal, 29, 1055—1062 60. Schall R, Müller FO, Duursema L, Groenewoud G, Hundt HKL, Middle MV, Mogilnicka EM, Swart KJ (1995). Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol. Arzneimittelforschung/Drug Research, 45, 1236—1239 61. Schall R, Müller FO, Hundt HKL, Ritter W, Duursema L, Groenewoud G, Middle MV (1995). No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin. Journal of Clinical Pharmacology, 35, 306—313 62. Müller FO, Schall R, de Vaal AC, Groenewoud G, Hundt HKL, Middle MV (1995). pharmacodynamics in healthy volunteers. European Journal of Clinical Pharmacology, 48, 247—251 63. Gagiano CA, Müller FGM, de Kock RF, Schall R (1995). Moclobemide in continuation treatment of major depressive episodes - an open follow-up study over six months. Journal of Clinical Psychopharmacology, 15, S46—S50 64. Gagiano CA, Müller FGM, Berk M, Joubert PM, Brown RGCW, Schall R (1995). Moclobemide twice daily in the treatment of major depressive episode - a double-blind, multicenter comparison with 3 times daily dosage schedules. Journal of Clinical Psychopharmacology, 15, S4—S9 65. Browning NG, Long MA, Barry R, Nel CJC, Schall R, Monk E (1995). Ruptured abdominal aortic aneurysms - prognostic indicators and complications affecting mortality. A local experience. South African Journal of Surgery, 33, 21—25 66. Schall R, Müller FO, Hundt HKL, Duursema L, Groenewoud G, Middle MV (1996). Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin. Arzneimittelforschung/Drug Research, 46, 41—46 67. Müller FO, Schall R, Mogilnicka EM, Groenewoud G, Hundt HKL, Luus HG, Middle MV, Swart KJ, de Vaal AC (1996). Relative bioavailability of four clomipramine hydrochloride tablet products. Biopharmaceutics and Drug Disposition, 17, 81—90 68. Luus HG, Müller FO, Groenewoud G, Hundt HKL, Schall R, van Dyk M (1996). Effect of ipsapirone HCl on plasma glucose and pharmacokinetics of ipsapirone in type I diabetics. Clinical Drug Investigation, 11, 159—166 69. Schall R, Williams RL (1996). Towards a practical strategy for assessing individual bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics, 24, 133—149 70. Müller FO, Schall R, Hundt HKL, Joubert A, Middle MV, Muir AR, Duursema L, Groenewoud G, Swart KJ (1996). Bioavailability of two selegiline hydrochloride tablet products. Arzneimittelforschung/Drug Research, 46, 1037-1040 71. Müller FO, Schall R, Hundt HKL, Groenewould G, Ungerer MJ, Cronje HS, Schumann F (1996). Pharmacokinetic profile of aprotinin in two patients with chronic renal failure (Letter). British Journal of Clinical Pharmacology, 41, 619—620 72. Müller FO, Claasen JP, Schall R, Mogilnicka EM, Vos J du T, Groenewoud G, Middle MV, Stulting AA (1996). The efficacy of two bupivacainehydrochloride injection products. South African Medical Journal, 86, 667—669 73. Swanepoel CR, Moosa MR, Rowland GF, Meyers AM, Botha BP, Smart AJ, Goodman R, Schall R, Keogh HJ, Merrifield EH (1996). Clinical experience with Repotin, a locally produced recombinant human erythropoietin, in the treatment of anaemia of chronic renal failure in South Africa. South African Medical Journal, 86, 1266—1269 74. Schall R, Müller FR, Müller FO, Luus HG (1997). Bioequivalence of controlled- release calcium antagonists. Clinical Pharmacokinetics, 32, 75—89 75. Richardt D, Rosmarin C, Havlik I, Schall R (1997). No effect of miglitol on the pharmacokinetics of phenytoin in healthy males. Clinical Drug Investigation, 13, 171 – 174 76. Müller FO, Terblanché J, Schall R, van Zyl Smit R, Tucker T, Marais K, Groenewoud G, Porchet HC, Weiner M, Hawarden D (1997). Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency. British Journal of Clinical Pharmacology, 44, 335—341 77. Müller FO, Middle MV, Schall R, Terblanché J, Hundt HKL, Groenewoud G (1997). An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure. British Journal of Clinical Pharmacology, 44, 393—398 78. Sirgel FA, Both FJ, Parkin DP, van de Wal BW, Schall R, Donald PR, Mitchison DA (1997). The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine, 156, 901—905 79. Jacobs P, Wood L, Schall R (1998). Cost effectiveness of G:CSF in chemotherapy and transplant-related neutropenia. Hematology, 3, 487 – 493 80. Stillings M, Havlik I, Chetty M, Clinton C, Schall R, Moodley I, Muir N, Little S (2000). Comparison of the pharmacokinetic profiles of soluble aspirin and solid paracetamol tablets in fed and fasted volunteers. Current Medical Research and Opinion, 16, 115 – 124 81. Opie LH, Schall R (2002). Evidence-based evaluation of calcium channel blockers for hypertension. Equality of mortality and cardiovascular risk relative to conventional therapy. Journal of the American College of Cardiology, 39, 315 – 322 82. Schug BS, Brendel E, Chantraine E, Wolf D, Martin W, Schall R, Blume HH (2002). The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast. British Journal of Clinical Pharmacology, 53, 582 – 588 83. Potgieter GE, Groenewoud G, Jordaan PJ, Hundt HKL, Schall R, Kummer M, Sewarte-Ross G (2002). Pharmacokinetics of pipamperone from three different tablet formulations. Arzneimittelforschung/Drug Research, 52, 430 – 434 84. Nel M, Schall R, Nel DG, Joubert G (2002). A comparison of approximate confidence interval methods for the difference between two independent binomial proportions. South African Statistical Journal, 36, 77 – 95 85. The Zimbabwe, Bangladesh, South Africa (ZIMBASA) Dysentery Study Group (2002). A multicentre, randomised, double blind clinical trial of short course vs. standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. The Pediatric Infectious Disease Journal, 21, 1136–1141 86. Coetzee A, Blaine EM, Labadarios D, Schall R, Haus M (2002). Effect of 1% and 2% propofol on blood lipids during long-term sedation. South African Medical Journal, 92, 911 – 916 87. Heyns CF, Simonin M-P, Grosgurin P, Schall R, Porchet HC for the South African Triptorelin Study Group (2003). Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer. British Journal of Urology International, 92, 226 – 231 (DOI: 10.1046/j.1464-410X.2003.04308.x) 88. Opie LH, Schall R (2004). Old hypertensives and new diabetes. Journal of Hypertension, 22, 1453 – 1458 89. Clark J, Schall R (2007). Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy, 62, 1023 – 1028 (DOI:10.1111/j.1398-9995.2007.01469.x) 90. Van Zyl JM, Schall R (2010). Weighted estimation of the location parameter of a symmetric stable distribution. South African Statistical Journal, 44, 1 – 16 91. Schall R, Ring A (2010). Statistical characterization of QT prolongation. Journal of Biopharmaceutical Statistics, 20, 543 – 562 (DOI: 10.1080/10543400903581978) 92. Schall R, Endrenyi L, Ring A (2010). Residuals and outliers in replicate design crossover studies. Journal of Biopharmaceutical Statistics, 20, 835 – 849 (DOI: 10.1080/10543401003618876) 93. Rossouw S, Joubert G, Schall R (2010). Profile of clinical trial biostatisticians and university courses to train them in South Africa. South African Statistical Journal, 44, 209 – 234 94. Schall R, Ring A (2011). Mixed models for data from thorough QT studies: Part 1. Assessment of marginal QT prolongation. Pharmaceutical Statistics, 10, 265 – 276 (DOI: 10.1002/pst.463) 95. Schall R (2011). Mixed models for data from thorough QT studies: Part 2. One- step assessment of conditional QT prolongation. Pharmaceutical Statistics, 10, 293 – 301 (DOI: 10.1002/pst.465) 96. Janse van Rensburg E, Tait K, Watt A, Schall R (2011). Comparative Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2 Test using the TaqMan 48 Analyzer (CAP/CTM-48 v2) and the Abbott Real Time HIV-1 Assay. Journal of Clinical Microbiology, 49, 377—379 (DOI: 10.1128/JCM.01285-10) 97. Schall R, Luus HG (2011). Comparative evaluation of ectoparasiticide efficacy: Non-inferiority and superiority assessment. Veterinary Parasitology, 178, 173 – 179 (DOI: 10.1016/j.vetpar.2010.12.028) 98. Van Zyl JM, Schall R (2012). Weighted least-squares rank regression for estimation of parameters with specific reference to the Weibull and Gumbel distribution. Communications in Statistics - Simulation and Computation, 41, 1654 – 1666 (DOI: 10.1080/03610918.2011.611315) 99. Verster A, de Waal D, Schall R, Prins C (2012). A truncated Pareto model for estimation of under recovery of large diamonds in diamond mining. Mathematical Geosciences, 44, 91 – 100 (DOI 10.1007/s11004-011-9374-1) 100. Schall R (2012). The empirical coverage of confidence intervals: Point estimates and confidence intervals for confidence levels. Biometrical Journal, 54, 537 – 551 (DOI: 10.1002/bimj.201100134) 101. Van Heerden N, Steyn HJH, Schall R (2012). Soil removal efficacy of catholyte on polyamide 6,6 fabric. Chinese Business Review, 11, 682 – 689. 102. Schall R, Weatherall D (2013). Accuracy and fairness of rain rules for interrupted one-day cricket matches. Journal of Applied Statistics, 40, 2462 – 2479 (DOI: 10.1080/02664763.2013.818623) 103. Cronjé N, Steyn HJH, Schall R (2013). A comparison of the influence of catholyte vs phosphate detergent on the mechanical properties of poyamide 6,6 woven fabric. Journal of Family Ecology and Consumer Sciences, 41, 1 – 11 104. Joubert H, Viljoen M, Schall R (2013). Performance of first-year accounting students: does time perspective matter? Acta Academica, 45, 242 – 267 Other articles in peer-reviewed journals

1. Schall R, Dunne TT (1989). Discussion of a paper by A.G. Bruce and R.D.
Martin. Journal of the Royal Statistical Society, Ser. B, 51, 415 2. Schall R (1990). Statistical analysis of HIV prevalence (Letter). South African 3. Schall R, Padayachee GN, Yach D (1990). The case for HIV surveillance in South Africa (Editorial). South African Medical Journal, 77, 324—325 4. Schall R, Padayachee N (1990). Doomsday forecasts of the AIDS epidemic (Opinion). South African Medical Journal, 78, 503 5. Schall R, Bradshaw D (1991). Statistics in medical publications (Letter). South 6. Schall R (1991). Doomsday Doomsday forecasts of the AIDS epidemic – whither Durban? (Author reply to letter to the editor). South African Medical Journal, 79, 566 7. Schall R (1997). Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar (Author reply to letter to the editor). Biometrics, 53, 383—384 8. Schall R (2001). Review of: Design and Analysis of Bioavailability and Bioequivalence Studies, Second Edition, by Shein-Chung Chow and Jen-Pei Liu, Marcel Dekker, New York, 2000. Controlled Clinical Trials, 22, 402 – 404 9. Schall R (2004). Review of: Testing Statistical Hypotheses of Equivalence, by Stefan Wellek, Chapman & Hall/CRC, Boca Raton, 2003. Clinical Trials, 1, 139 – 140 10. Schall R (2010). Review of: Design and Analysis of Bioavailability and Bioequivalence Studies, Third Edition, by Shein-Chung Chow and Jen-Pei Liu, Chapman & Hall / CRC, Boca Raton, 2009. Journal of the American Statistical Association, 105, 445 11. Schall R, Endrenyi L (2010). Bioequivalence: tried and tested (Editorial). Cardiovascular Journal of Africa, 21, 69 – 71 Chapters in books

1. Schall R, Dunne TT (1989). Perturbation scheme specific residuals.
Proceedings of the Business and Economics Statistics Section, American Statistical Association 2. Joubert G, Schall R (1991). Some statistical concepts. In: Child Health For All. Kibel MA, Wagstaff LA (eds). Cape Town: Oxford University Press, 380—385 3. Joubert G, Schall R (1995). Some statistical concepts. In: Child Health For All, 2nd Edition. Kibel MA, Wagstaff LA (eds). Cape Town: Oxford University Press, 428—433 4. Schall R (1995). A unified view of individual, population, and average bioequivalence. In: BIO-International 2. Bioavailability, bioequivalence and pharmacokinetic studies. Blume HH, Midha KK (eds). Stuttgart: Medpharm Scientific Publishers, 91—106 5. Schall R (1996). Individual bioequivalence: Update on scientific and regulatory progress. In: Bioavailability, bioequivalence and pharmacokinetic studies. Midha KK, Nagai T (eds), Tokyo: Business Center for Academic Societies Japan, 119—123 6. Schall R, Harris S (1998). Analysis of patient data. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 134—140 7. Schall R, Harris S (1998). Analysis plan and sets. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 330—334 8. Schall R, Harris S (1998). Missing values and outliers. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 335—336 9. Schall R (1998). When and why are statistical trial decisions needed: the role of the statistician. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 216—219 10. Schall R, Luus HG, Erasmus TP (1998). Type of comparison. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 258—266 11. Erasmus TP, Schall R (1998). Subgroups, interactions and covariates. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 362—364 12. Erasmus TP, Schall R (1998). Evaluation of safety and tolerability: Scope. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 373—374 13. Erasmus TP, Schall R (1998). Evaluation of safety and tolerability: Variables and data collection. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 375—377 14. Erasmus TP, Schall R (1998). Evaluation of safety and tolerability: Subjects and presentation of data. In: Introduction to Clinical Trials. Karlberg J, Tsang K (eds), Hong Kong: Clinical Trials Centre, The University of Hong Kong, 378—384 15. Hauschke D, Schall R, Luus HG (2000). Statistical significance. In: Encyclopedia of Biopharmaceutical Statistics. Chow S-C (ed), New York: Marcel Dekker, 493 – 497 16. Chikobvu P, Joubert G, Steinberg H, van der Ryst E, Schall R (2003). Follow-up in longitudinal studies in the presence of HIV/AIDS: The Bloemfontein vitamin A trial. A case study. Bulletin of the International Statistical Institute 54th Session Proceedings, LX, 128 – 131 17. Hauschke D, Schall R, Luus HG (2003). Statistical significance. In: Encyclopedia of Biopharmaceutical Statistics. 2nd Edition. Chow S-C (ed), New York: Marcel Dekker, 954 – 958
Literary translations

1. GR von Wielligh (2005). Die Sterne sind glühende Kohlen und Asche.
Buschmann-Erzählungen: Mythologie und Legenden. Edited and translated into German by Robert Schall. Windhoek: Kuiseb Publishers (Namibia Scientific Society) (http://www.kuiseb-verlag.com/product_info.php?cPath=2&products_id=78) 2. Minnie Postma (2009). Im Anfang (In die begin). Translated into German by Robert Schall. In: Mythos Südafrika. Literarischer Reiseführer Südafrika. Hausberg KP (ed), Köln: JP Bachem Verlag, 167 – 172 (http://www.bachem.de/verlag/buecher/sagen-und-geschichten/mythos-sudafrika/?searchterm=) 3. Minnie Postma (2009). Der kleine Junge Senkatane (Die klein seuntjie Senkatane). Translated into German by Robert Schall. In: Mythos Südafrika. Literarischer Reiseführer Südafrika. Hausberg KP (ed), Köln: JP Bachem Verlag, 173 – 179 (http://www.bachem.de/verlag/buecher/sagen-und-geschichten/mythos-sudafrika/?searchterm=) 4. Schall R (2009). Translation into German of Somerkersfees (Sommerweihnacht) by Koos du Plessis. Newsletter of the Namibia Scientific Society, 51 (1-4) 16 – 17 5. Schall R (2010). Translations into German of three poems by MM Walters (from: Apocrypha. Nasionale Boekhandel, Cape Town, 1969). Stilet, XXII:2, 203 – 205 (http://versindaba.co.za/2011/05/08/mm-walters-vertaling-in-duits/) 6. Schall R (2011). Translations into German of three poems by George Weideman (from: Verskombuis. Protea Book House, Pretoria, 2006). Stilet, in press 7. Schall R (2011). Translations into German of five poems by Boerneef (from: Versamelde Poësie. Tafelberg, Cape Town, 1977). Stilet, XXIII:1, 156 – 157 (http://versindaba.co.za/2012/01/30/boerneef-vertaling-in-duits/) 8. Schall R (2011). Translation into German of Karnaval van die Diere (Karneval der Tiere) by Philip de Vos. (http://versindaba.co.za/2011/12/12/philip-de-vos-vertaling-in-duits/) 9. Schall R (2011). Translation into German of four poems by NP van Wyk Louw (from: Tristia. Human & Rousseau, 1975). Literator, 32, 206 – 207 (http://versindaba.co.za/2012/12/04/np-van-wyk-louw-vertaling-in-duits-2/) Other articles

1. Schall R (2000). ABO: Dagboek vertel verhaal van stille held in oorlog.
Bloemfontein: Volksblad, 20 May 2000 2. Schall R (2012). Ons witmuurlegplekwoninkie (of: Die praktiese nut van ’n http://versindaba.co.za/2012/10/16/robert-schall-ons- 3. Schall R (2012). Tikfout innie Tankwa (… én in Boerneef se Versamelde Poësie) (http://versindaba.co.za/2012/11/06/robert-schall-tikfout-innie-tankwa/)

Source: http://apps.ufs.ac.za/dl/staff/0064733/cv.pdf

8325_banner gel cloro

DEFIR S.r.l. Revisione n.8 Data revisione 05/10/2011 Stampata il 05/10/2011 BANNER GEL CLORO Scheda Dati di Sicurezza 1. Identificazione della sostanza o della miscela e della società/impresa 1.1. Identificatore del prodotto BANNER GEL CLORO 1.2. Pertinenti usi identificati della sostanza o miscela e usi sconsigliati Detergente igienizzante liquido cloroattivo 1.3. Inf

Stockholms idrottsnÄmnd protokoll nr 10/1999

STOCKHOLMS IDROTTSNÄMND PROTOKOLL NR 10/1999 Torsdagen den 30 september1999, kl. 17.00–18.35 Drätselnämndens sessionssal, Stadshuset Justerat Alf T. Samuelsson Ledamöter: Alf T. Samuelsson (kd) Louise Andersson Austern (m) Berthold Gustavsson (m) Anders Jutterström (s) Rolf Pettersson (s) Caroline Silverudd Lundbom (fp) Stefan Sjöberg (v) Annett Öhman Kar

Copyright © 2018 Predicting Disease Pdf